3D Medicines Inc. (1244.HK)

HKD 3.34

(-1.47%)

Operating Income Summary of 3D Medicines Inc.

  • 3D Medicines Inc.'s latest annual operating income in 2023 was -497.24 Million CNY , up 51.87% from previous year.
  • 3D Medicines Inc.'s latest quarterly operating income in 2024 Q2 was -35.15 Million CNY , down 0.0% from previous quarter.
  • 3D Medicines Inc. reported an annual operating income of -996.46 Million CNY in 2022, up 31.67% from previous year.
  • 3D Medicines Inc. reported an annual operating income of -1.45 Billion CNY in 2021, down -132.42% from previous year.
  • 3D Medicines Inc. reported a quarterly operating income of -35.15 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • 3D Medicines Inc. reported a quarterly operating income of -104.88 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of 3D Medicines Inc. (2023 - 2020)

Historical Annual Operating Income of 3D Medicines Inc. (2023 - 2020)

Year Operating Income Operating Income Growth
2023 -497.24 Million CNY 51.87%
2022 -996.46 Million CNY 31.67%
2021 -1.45 Billion CNY -132.42%
2020 -627.47 Million CNY 0.0%

Peer Operating Income Comparison of 3D Medicines Inc.

Name Operating Income Operating Income Difference
Uni-Bio Science Group Limited 67.76 Million HKD 833.749%
CK Life Sciences Int'l., (Holdings) Inc. 897.95 Million HKD 155.376%